If you would like further information on any of the companies profiled below please contact us.
Please Note:
The information posted below is not, and should not be regarded as, an offer of securities to the public. Investment opportunities will only be offered to, and may only be taken up by, persons who are “eligible persons” in terms of section 5(2CC) of the Securities Act 1978 or who are otherwise entitled to receive an offer of securities without a prospectus and investment statement (for example, where the offer is made under the Securities Act (Venture Capital Schemes) Exemption Notice 2008). Interested parties should contact Pacific Channel and will be required to provide confirmation that they are “eligible persons” or otherwise qualify to receive further information. No expression of interest will involve an obligation or commitment of any kind. If you are not familiar with the provisions of the Securities Act 1978, please consult with your professional advisor.
1. A company is developing and intends to commercialise superior prostate cancer diagnostics. The company’s plan is to progress its diagnostic tests for prostate cancer through clinical studies to market. The company intends its tests to be adopted globally as gold standard prostate cancer diagnostics.
2. A company has developed novel methods to encapsulate, blend and deliver polychromatic natural pigments in dry form for tinting paint at the point of use. The system allows the colour to be sold both through the current paint/hardware store channel, as well as to exploit new supply chains including direct sales of colour through internet to the end-user.
3. A company is marketing a natural product proven to enhance physiological performance of horses – primarily for the racing and sport horse markets.
4. A company is developing a continuous filtration system with potential applications in dairy, wine, waste water and mining industries. The technology is designed to provide continuous liquid filtration to remove solids from waste effluent.
5. A company has developed a non-invasive device that measures arterial stiffness – a superior indicator of cardiovascular risk than only assessing a patient’s blood pressure. The technology, BPplus®, is an easy-to-use device, proven to provide repeatable, reproducible and robust results.
6. A company intends to establish marine energy power stations in small population islands in the South Pacific to generate electricity in a way that is sustainable and cheaper than electricity generated using diesel.
7. A company formed to sell innovatively designed New Zealand wool carpets, with a novel manufacturing process that allows for a fully natural product, targetted at high-end residential and commercial markets.
8. A company has developed a low cost, rapid toxicity and nutrient content analyser to meet the critical need to protect and improve waste water treatment plants world-wide.